Myles Minter

Biotech Equity Research Analyst at William Blair

Role
Biotech Equity Research Analyst at William Blair
Location
Boston, MA, US
LinkedIn followers
500 followers
Finance & AccountingView LinkedIn profile

About Myles Minter

Myles is a sell-side equity research analyst with a passion to provide informed investment opinions within the biotechnology realm. Previously a postdoctoral biomedical scientist contributing to our knowledge of brain function in health and disease, he also maintains significant interests in technology transfer and intellectual property protection across broad scientific fields. His primary goal is to support scientific endeavors from discovery to market, ensuring public benefit from exciting innovations in healthcare.

Experience

  1. Biotech Equity Research Analyst

    William Blair

    Sep 2019 — Present · Boston, MA, US

    Research analyst covering targeted neurology and genetic medicines.Current coverage: ALEC, ALNY, ANRO, ARCT, ARGX, AXSM, BHVN, BIIB, BNOX, IONS, KRRO, LRMR, MRNA, NBIX, NMRA, NTLA, SLN, TRDA, VERV, VRTX, VTGN, XENE

Education

  • University of Melbourne

    Doctor of Philosophy (PhD), Neuropharmacology

    2011 — 2015

  • University of Melbourne

    Bachelor of Biomedical Science (B.BiomedSci), Neuropharmacology

    2007 — 2009

  • Ivanhoe Grammar School

    Victorian Certificate of Education (VCE), Science and Economics

    1995 — 2006

  • University of Melbourne

    Bachelor of Science, Degree with Honours (BSc Hons), Neuropharmacology

    2010 — 2010

Skills

  • Behavioral Neuroscience
  • Cytokines
  • Neurodegeneration
  • Regulatory Analysis
  • Cognitive Neuroscience
  • Competitive Analysis
  • In Vitro
  • Kol Identification
  • Equity Research
  • Kol Management
  • Market Analysis
  • Alzheimer's Disease
  • Life Sciences
  • Intellectual Property
  • Healthcare Analytics
  • Neuroscience
  • Western Blotting
  • Due Diligence
  • Molecular Biology
  • Market Evaluations
  • Polymerase Chain Reaction (Pcr)
  • Inflammation
  • Business Development
  • Molecular Cloning
  • Animal Models
  • Science
  • Immunoblotting
  • Biochemistry
  • Research
  • Healthcare Consulting
  • Protein Assays
  • Scientific Writing
  • Investment Strategies
  • Neurodegenerative Disease
  • Histology
  • Clinical Trial Analysis
  • Anti-Inflammatory
  • Brain Injury
  • Commercialization
  • Cell Culture

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Myles Minter — Biotech Equity Research Analyst at William Blair in Boston, MA, US | Unifers